Mycobacterium triplex pulmonary disease in immunocompetent host.
Mycobacterium triplex, a recently described, potentially pathogenic species, caused disease primarily in immunocompromised patients. We report a case of pulmonary infection due to this mycobacterium in an immunocompetent patient and review the characteristics of two other cases. In our experience, Mycobacterium triplex pulmonary infection is unresponsive to antimycobacterial chemotherapy.
Piersimoni
Claudio
C
Department of Clinical Microbiology, United Hospitals, I-60020 Ancona, Italy. piersim@tin.it
Zitti
Piergiorgio
P
Mazzarelli
Gianna
G
Mariottini
Allessandro
A
Nista
Domenico
D
Zallocco
Diego
D
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001483:Base Sequence; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D006801:Humans; D007121:Immunocompetence; D008171:Lung Diseases / Q000382:microbiology*; D008875:Middle Aged; D008969:Molecular Sequence Data; D009161:Mycobacterium / Q000145:classification; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D013045:Species Specificity
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D012336:RNA, Ribosomal, 16S